|
ASPM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.511200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.613800E-01 |
| Normal-vs-Stage2 |
1.440550E-01 |
| Normal-vs-Stage3 |
9.631200E-01 |
| Normal-vs-Stage4 |
4.947400E-01 |
| Stage1-vs-Stage2 |
4.815200E-04 |
| Stage1-vs-Stage3 |
8.336200E-01 |
| Stage1-vs-Stage4 |
3.134800E-01 |
| Stage2-vs-Stage3 |
8.177600E-03 |
| Stage2-vs-Stage4 |
5.095800E-03 |
| Stage3-vs-Stage4 |
2.619800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.497400E-01 |
| Normal-vs-AfricanAmerican |
6.565600E-01 |
| Normal-vs-Asian |
9.774400E-01 |
| Caucasian-vs-AfricanAmerican |
4.232400E-01 |
| Caucasian-vs-Asian |
7.381800E-01 |
| AfricanAmerican-vs-Asian |
5.840400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.899400E-01 |
| Normal-vs-Female |
8.907400E-01 |
| Male-vs-Female |
5.323000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.143600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.039800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.787200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.254300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.700600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.633600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.343410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.223800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.910300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.060010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.664200E-01 |
| Classical-VS-Follicular |
1.42999999952487E-07 |
| Classical-VS-Other |
2.854200E-02 |
| Classical-VS-Normal |
7.102400E-01 |
| Tall-VS-Follicular |
9.297800E-03 |
| Tall-VS-Other |
5.056300E-02 |
| Tall-VS-Normal |
5.213600E-01 |
| Follicular-VS-Other |
7.230000E-01 |
| Follicular-VS-Normal |
1.200410E-01 |
| Other-VS-Normal |
2.779400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.499800E-01 |
| Normal-vs-N1 |
9.816600E-01 |
| N0-vs-N1 |
2.944000E-01 |
|
|
